Clinical Trial Update: Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial compares cytarabine alone versus cytarabine with VNP40101M in relapsed acute myeloid leukemia. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• VNP40101M

Snippet

Sponsor: Vion Pharmaceuticals | Conditions: Leukemia | Phase 3 | Status: COMPLETED